Compounds > ammonium tungsten antimonate hydroxide oxide
Page last updated: 2024-09-04

ammonium tungsten antimonate hydroxide oxide and foscarnet

ammonium tungsten antimonate hydroxide oxide has been researched along with foscarnet in 6 studies

Compound Research Comparison

Studies
(ammonium tungsten antimonate hydroxide oxide)		Trials
(ammonium tungsten antimonate hydroxide oxide)		Recent Studies (post-2010)
(ammonium tungsten antimonate hydroxide oxide)		Studies
(foscarnet)		Trials
(foscarnet)		Recent Studies (post-2010) (foscarnet)
40201,682116257

Protein Interaction Comparison

ProteinTaxonomyammonium tungsten antimonate hydroxide oxide (IC50)foscarnet (IC50)
DNA polymerase catalytic subunitHuman herpesvirus 5 strain AD1692.5
DNA polymerase catalytic subunitHuman herpesvirus 3 strain Dumas0.28
Reverse transcriptase/RNaseH Human immunodeficiency virus 12.42

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19906 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hirsch, MS; Kaplan, JC1
Katinka, MD1
Kaplan, JC; Sandström, EG1
Broder, S; Yarchoan, R1
Sandström, E1
Weber, J1

Reviews

4 review(s) available for ammonium tungsten antimonate hydroxide oxide and foscarnet

ArticleYear
Prospects of therapy for infections with human T-lymphotropic virus type III.
    Annals of internal medicine, 1985, Volume: 103, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Antimony; Antiviral Agents; Combined Modality Therapy; Deltaretrovirus; Foscarnet; Humans; Immunotherapy; Interferons; Lactams, Macrocyclic; Phosphonoacetic Acid; Receptors, Virus; Reverse Transcriptase Inhibitors; Ribavirin; RNA Processing, Post-Transcriptional; RNA, Viral; Suramin; Tungsten; Tungsten Compounds; Virus Replication

1985
Antiviral therapy in AIDS. Clinical pharmacological properties and therapeutic experience to date.
    Drugs, 1987, Volume: 34, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Forecasting; Foscarnet; Immunotherapy; Phosphonoacetic Acid; Rifabutin; Rifamycins; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine

1987
Progress in the development of antiviral therapy for HTLV-III-associated diseases.
    Important advances in oncology, 1987

    Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Foscarnet; HIV; Humans; Phosphonoacetic Acid; Ribavirin; Rifabutin; Rifamycins; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine

1987
Antiviral drugs for AIDS. Current status and future prospects.
    Drugs, 1986, Volume: 31, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Foscarnet; Humans; Interferon Type I; Phosphonoacetic Acid; Ribavirin; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine

1986

Other Studies

2 other study(ies) available for ammonium tungsten antimonate hydroxide oxide and foscarnet

ArticleYear
RNA-dependent DNA polymerase activity in Paramecium tetraurelia: what for?
    European journal of biochemistry, 1987, Mar-16, Volume: 163, Issue:3

    Topics: Animals; Antimony; Avian Myeloblastosis Virus; Cell Cycle; Centrifugation, Density Gradient; Dose-Response Relationship, Drug; Ethidium; Foscarnet; Magnesium; Manganese; Paramecium; Phosphonoacetic Acid; RNA-Directed DNA Polymerase; Suramin; Templates, Genetic; Tungsten; Tungsten Compounds

1987
AIDS: the virus, antivirals and vaccines.
    British journal of hospital medicine, 1987, Volume: 37, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Foscarnet; Genes, Viral; HIV; Humans; Phosphonoacetic Acid; Suramin; Thymidine; Tungsten; Tungsten Compounds; Viral Vaccines; Virus Replication; Zidovudine

1987